Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$215 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$0 Mln
ROE
-63.4 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
36.6
Industry P/E
54.26
EV/EBITDA
-2.3
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
35,270,900
CFO
$-136.85 Mln
EBITDA
$-246.16 Mln
Net Profit
$-233.24 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Biosig Technologies Inc (BSGM)
| -- | -- | -- | -- | -14.8 | -37.8 | -18.8 |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|---|
|
Biosig Technologies Inc (BSGM)
| 13.1 | -81.2 | -42.8 | -34.1 | 38.6 | 18.5 | 11.6 |
|
S&P Small-Cap 600
| 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Biosig Technologies Inc (BSGM)
|
5.0 | 215.2 | 0.0 | -26.2 | -211,400.0 | -- | -- | 36.6 |
| 6.0 | 243.8 | 0.4 | -17.9 | -3,436.1 | -155 | -- | 28.0 |
BioSig Technologies, Inc., a medical technology company, provides digital signal processing technology platform services in the United States. The company offers PURE EP Platform that delivers insights to electrophysiologists for ablation treatments... of cardiovascular arrhythmias. It has a research agreement with Mayo Foundation with the right to sublicense for patent applications in the fields of signal processing, physiologic recording, electrophysiology recording, electrophysiology software, and autonomics to develop, make, and offer for sale. The company also designs and develops an online platform for real-world asset (RWA) tokenization. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Los Angeles, California. Read more
President, Principal Executive Officer & Executive VP
Mr. Frederick D. Hrkac
President, Principal Executive Officer & Executive VP
Mr. Frederick D. Hrkac
Headquarters
Los Angeles, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Biosig Technologies Inc (BSGM) is $5.01 (NASDAQ) as of 10-Oct-2025 09:30 EDT. Biosig Technologies Inc (BSGM) has given a return of -14.82% in the last 3 years.
Since, TTM earnings of Biosig Technologies Inc (BSGM) is negative, P/E ratio is not available.
The P/B ratio of Biosig Technologies Inc (BSGM) is 36.58 times as on 10-Oct-2025, a 1140 premium to its peers’ median range of 2.95 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
--
|
--
|
|
2023
|
-0.15
|
-1.47
|
|
2022
|
-0.08
|
5.16
|
|
2021
|
-0.25
|
0.64
|
|
2020
|
-0.23
|
0.49
|
The 52-week high and low of Biosig Technologies Inc (BSGM) are Rs 5.69 and Rs 4.97 as of 04-Apr-2026.
Biosig Technologies Inc (BSGM) has a market capitalisation of $ 215 Mln as on 10-Oct-2025. As per SEBI classification, it is a Small Cap company.
Before investing in Biosig Technologies Inc (BSGM), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$4.52
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.